PubRank

Harvey J Alter

Author PubWeight™ 67.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retracted Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 2010 4.31
2 Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003 2.45
3 Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology 2013 2.17
4 Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Natl Acad Sci U S A 2002 2.04
5 A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002 2.02
6 Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci U S A 2008 1.82
7 Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity. Proc Natl Acad Sci U S A 2009 1.72
8 Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. Proc Natl Acad Sci U S A 2007 1.66
9 Investigation of residual hepatitis C virus in presumed recovered subjects. Hepatology 2012 1.61
10 Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components. Transfusion 2011 1.59
11 Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 2011 1.56
12 Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes. Blood 2012 1.45
13 HCV natural history: the retrospective and prospective in perspective. J Hepatol 2005 1.40
14 Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. Hepatology 2003 1.39
15 Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity. Hepatology 2005 1.38
16 An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 2013 1.36
17 Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 2003 1.34
18 Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 2006 1.31
19 Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci U S A 2003 1.26
20 A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proc Natl Acad Sci U S A 2007 1.24
21 Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion 2003 1.19
22 Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis 2003 1.18
23 Hepatitis C: the end of the beginning and possibly the beginning of the end. Ann Intern Med 2012 1.18
24 Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies. Virol J 2009 1.17
25 Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci U S A 2006 1.11
26 Genomic scale analysis of racial impact on response to IFN-alpha. Proc Natl Acad Sci U S A 2009 1.08
27 Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)(1). FEBS Lett 2002 1.04
28 Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection. J Virol 2005 1.03
29 Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J Pediatr 2007 1.01
30 Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. Proc Natl Acad Sci U S A 2012 1.01
31 Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005 1.00
32 Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees. Proc Natl Acad Sci U S A 2006 0.97
33 SEN virus: epidemiology and characteristics of a transfusion-transmitted virus. Transfusion 2005 0.97
34 SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C. Hepatology 2002 0.93
35 Evolutionary analysis of hepatitis C virus gene sequences from 1953. Philos Trans R Soc Lond B Biol Sci 2013 0.92
36 Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes. J Gen Virol 2004 0.90
37 A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. J Infect Dis 2012 0.90
38 Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 2011 0.90
39 Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002 0.88
40 Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV. J Infect Dis 2009 0.88
41 Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion 2010 0.88
42 Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C. Hepatology 2006 0.87
43 Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. Immunology 2007 0.87
44 Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization. Hepatology 2003 0.86
45 The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling. Transfusion 2012 0.85
46 Prevalence of SEN viruses among injection drug users in the San Francisco Bay area. J Infect Dis 2003 0.81
47 To have B or not to have B: vaccine and the potential eradication of hepatitis B. J Hepatol 2012 0.81
48 Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants. Vaccine 2008 0.80
49 The epidemiology of transfusion-associated hepatitis C in a children's hospital. Transfusion 2007 0.80
50 The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells. Virology 2013 0.80
51 Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs. J Infect Dis 2006 0.79
52 Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration. Lab Invest 2005 0.77
53 A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. Virology 2006 0.77
54 Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus. J Transl Med 2015 0.76
55 Isolation of human monoclonal antibodies to the envelope e2 protein of hepatitis C virus and their characterization. PLoS One 2013 0.76
56 Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors. Transfusion 2014 0.75
57 Blood system changes since recognition of transfusion-associated AIDS. Transfusion 2013 0.75
58 PCR-probe capture hybridization assay and statistical model for SEN virus prevalence estimation. J Med Virol 2004 0.75
59 Understanding the natural history of chronic HBV and HCV infections. J Fam Pract 2010 0.75